HIGHLIGHTS
- who: Metin Yusuf Gelmez from the University of Minnesota Twin Cities, United States have published the paper: Immune modulation as a consequence of SARS-CoV-2 infection, in the Journal: (JOURNAL)
- what: The studies showed that lymphopenia and immune_responses detected in COVID-19 patients were associated with disease progression . The studies showed that tocilizumab has a low effect on parameters such as D-dimer and lymphocytes, but influences on CRP and ferritin enough to be clinically important . In the study , CD57-expressing NK cells were analyzed in mild, moderate and severe patients and no differences . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.